TRImaran Pharma is a newly formed start-up venture with plans to develop some promising drug compounds for the treatment of PTSD, MDD and ADHD.
These compounds were in-licensed from a mid-west University and are patent protected through 2033. We're looking for $500K to fund the initial PoP development effort.